Top-News

Dicerna Pharmac News

Keine aktuellen Kursdaten verfügbar
WKN: A1XCYU
ISIN: US2530311081
US-Symbol: DRNA
Typ: Aktie

Dicerna Pharmac News

01.04.22 - Der Aktionär
Speku­latio­nen um Alnylam – Biotech‑Aktie gibt kräftig Gas
14.12.21 - PR Newswire
DICERNA INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Dicerna Pharmaceuticals, Inc. - DRNA
DICERNA INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of ...
09.12.21 - PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Companies - ROG, PAE, MNTV, CSPR, VLY, DRNA
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Companies - ROG, PAE, MNTV, CSPR, VLY, DRNA PR Newswire
09.12.21 - PR Newswire
Direxion Launches mRNA ETF (MSGR)
Direxion Launches mRNA ETF (MSGR) MSGR Offers Exposure to Rapidly Evolving mRNA Sector PR Newswire
07.12.21 - PR Newswire
SHAREHOLDER ALERT: WeissLaw LLP Reminds VG, DRNA, DVD, and COR Shareholders About Its Ongoing Investigations
SHAREHOLDER ALERT: WeissLaw LLP Reminds VG, DRNA, DVD, and COR Shareholders About Its Ongoing Investigations PR Newswire
02.12.21 - PR Newswire
SHAREHOLDER ALERT: WeissLaw LLP Reminds STXB, DRNA, DVD and VSAT Shareholders About Its Ongoing Investigations
SHAREHOLDER ALERT: WeissLaw LLP Reminds STXB, DRNA, DVD and VSAT Shareholders About Its Ongoing Investigations PR Newswire
26.11.21 - PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates CONE, VLY, DRNA, CSPR; Shareholders are Encouraged to Contact the Firm
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates CONE, VLY, DRNA, CSPR; Shareholders are Encouraged to Contact the Firm PR Newswire
24.11.21 - PR Newswire
SHAREHOLDER ALERT: WeissLaw LLP Reminds DRNA, IHC, NE, and ABTX Shareholders About Its Ongoing Investigations
SHAREHOLDER ALERT: WeissLaw LLP Reminds DRNA, IHC, NE, and ABTX Shareholders About Its Ongoing Investigations PR Newswire
22.11.21 - PR Newswire
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Dicerna Pharmaceuticals, Inc. - DRNA
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Dicerna Pharmaceuticals, Inc. - DRNA PR Newswire
20.11.21 - PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates COR, DRNA, STXB, BCML; Shareholders are Encouraged to Contact the Firm
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates COR, DRNA, STXB, BCML; Shareholders are Encouraged to Contact the Firm PR Newswire
19.11.21 - PR Newswire
DICERNA INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Dicerna Pharmaceuticals, Inc. - DRNA
DICERNA INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of ...
18.11.21 - PR Newswire
SHAREHOLDER ALERT: WeissLaw LLP Investigates Dicerna Pharmaceuticals, Inc.
SHAREHOLDER ALERT: WeissLaw LLP Investigates Dicerna Pharmaceuticals, Inc. PR Newswire
18.11.21 - Der Aktionär
Übernahme‑Hammer! Novo Nordisk greift nach diesem Ver10facher‑Kandidaten – 80 Prozent Aufschlag!
18.11.21 - PR Newswire
Shareholder Alert: Ademi LLP investigates whether Dicerna Pharmaceuticals, Inc. has obtained a Fair Price in its going private transaction with Novo Nordisk
Shareholder Alert: Ademi LLP investigates whether Dicerna Pharmaceuticals, Inc. has obtained a Fair Price in its going private transaction with Novo Nordisk PR Newswire
18.11.21 - PR Newswire
Thinking about buying stock in Dicerna Pharmaceuticals, Cloopen Group, Calithera Biosciences, ZTO Express, or Macy's?
Thinking about buying stock in Dicerna Pharmaceuticals, Cloopen Group, Calithera Biosciences, ZTO Express, or Macy's? PR Newswire
12.02.19 - PR Newswire
Pioneer in Taking RNA Therpeutics Through the Clinic Joins Skyhawk Therapeutics as Chief Medical Officer
Pioneer in Taking RNA Therpeutics Through the Clinic Joins Skyhawk Therapeutics as Chief Medical Officer PR Newswire
29.10.18 - PR Newswire
Lilly and Dicerna Announce RNAi Licensing and Research Collaboration
Lilly and Dicerna Announce RNAi Licensing and Research Collaboration - Companies will collaborate on RNAi research for cardio-​metabolic, neurodegeneration and pain targets - ...

Newssuche

Videos

08:50 Uhr
Technical Trading: AUD/USD mit Mega Chance
AUD/USD Long Typ: Turbo Open End WKN: UM0EHU Hebel: 6,42 Laufzeit: OpenEnd Einstieg: Market ... Mehr »